Today’s clinical trial processes are becoming increasingly lengthy, costly, and complex. Extracting real-time patient data residing in healthcare organization electronic health records (EHRs) has become an apparent solution to bringing new therapies to market faster. Leveraging the detailed data within EHRs allows pharma and CRO companies to identify patients who match exactly the eligibility criteria for the cohort they are seeking. Success in extracting and leveraging EHR data has been seen in single institutions, and expanding this technology to network multiple healthcare organizations is now on the horizon. Examples of pharma and CRO companies using federated EHR data from multiple healthcare organizations to develop more feasible protocols and conduct targeted patient recruitment demonstrate early yet encouraging results. EHR data will soon become the key building block on which the drug development industry can employ to build more effective, efficient processes that will eventually lead to better clinical outcomes and more approved therapies to treat patients.
Upon completion of this Webinar, attendees should be able to:
Discuss benefits and downsides of utilizing EHR technology in planning and conducting clinical trials.
Explain how the extracting and leveraging of EHR data has been used successfully by pharma and CRO companies
Understand how EHR technology can ultimately enhance drug development processes to bring new therapies to market faster.